- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Zydus Lifesciences Limited — Updates, 04-08-2026: Press Release
04-08-2026 | 03:08 pm
04-08-2026 | 03:08 pm
Zydus secured USFDA final approval for Indocyanine Green for Injection, gaining 180-days CGT exclusivity. A swift launch is planned for this product, targeting a market with prior annual sales of approximately USD 125.8 million, strengthening its imaging portfolio.
No comments yet. Be the first to comment!